Guido Ferlazzo1, Christian Münz. 1. Laboratory of Immunology and Biotherapy, Department of Human Pathology, School of Medicine, University of Messina, Policlinico, Via Consolare Valeria, 98125 Messina, Italy. guido.ferlazzo@unime.it
Abstract
INTRODUCTION: In recent years, it has been realized that innate lymphocytes do not act in isolation but potentiate their efficiency by interacting with each other, resulting even in the regulation of adaptive immune response. One such cross-talk exists between dendritic cells (DCs) and natural killer (NK) cells. Here, we summarize recent studies on which subsets of these two innate immune components participate in this interaction, how it influences immune responses, and to which extent similar stimuli are integrated by DCs and NK cells during innate immunity. CONCLUSION: We suggest that this cross-talk should be harnessed by activating both of these innate leucocyte populations with new adjuvant formulations for immunotherapies.
INTRODUCTION: In recent years, it has been realized that innate lymphocytes do not act in isolation but potentiate their efficiency by interacting with each other, resulting even in the regulation of adaptive immune response. One such cross-talk exists between dendritic cells (DCs) and natural killer (NK) cells. Here, we summarize recent studies on which subsets of these two innate immune components participate in this interaction, how it influences immune responses, and to which extent similar stimuli are integrated by DCs and NK cells during innate immunity. CONCLUSION: We suggest that this cross-talk should be harnessed by activating both of these innate leucocyte populations with new adjuvant formulations for immunotherapies.
Authors: N C Fernandez; A Lozier; C Flament; P Ricciardi-Castagnoli; D Bellet; M Suter; M Perricaudet; T Tursz; E Maraskovsky; L Zitvogel Journal: Nat Med Date: 1999-04 Impact factor: 53.440
Authors: Christopher E Andoniou; Serani L H van Dommelen; Valentina Voigt; Daniel M Andrews; Geraldine Brizard; Carine Asselin-Paturel; Thomas Delale; Katryn J Stacey; Giorgio Trinchieri; Mariapia A Degli-Esposti Journal: Nat Immunol Date: 2005-09-04 Impact factor: 25.606
Authors: Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell Journal: Immunity Date: 2008-12-19 Impact factor: 31.745
Authors: A Moretta; S Sivori; M Vitale; D Pende; L Morelli; R Augugliaro; C Bottino; L Moretta Journal: J Exp Med Date: 1995-09-01 Impact factor: 14.307
Authors: Galit Alter; Daniel Kavanagh; Suzannah Rihn; Rutger Luteijn; David Brooks; Michael Oldstone; Jan van Lunzen; Marcus Altfeld Journal: J Clin Invest Date: 2010-05-03 Impact factor: 14.808
Authors: Francesca Bellora; Roberta Castriconi; Alessandra Dondero; Giorgio Reggiardo; Lorenzo Moretta; Alberto Mantovani; Alessandro Moretta; Cristina Bottino Journal: Proc Natl Acad Sci U S A Date: 2010-11-30 Impact factor: 11.205
Authors: Till Strowig; Obinna Chijioke; Paolo Carrega; Frida Arrey; Sonja Meixlsperger; Patrick C Rämer; Guido Ferlazzo; Christian Münz Journal: Blood Date: 2010-07-29 Impact factor: 22.113
Authors: Antonino Bruno; Chiara Focaccetti; Arianna Pagani; Andrea S Imperatori; Marco Spagnoletti; Nicola Rotolo; Anna Rita Cantelmo; Francesca Franzi; Carlo Capella; Guido Ferlazzo; Lorenzo Mortara; Adriana Albini; Douglas M Noonan Journal: Neoplasia Date: 2013-02 Impact factor: 5.715
Authors: Rodolfo D Vicetti Miguel; Robert L Hendricks; Alfredo J Aguirre; Melissa A Melan; Stephen A K Harvey; Tracy Terry-Allison; Anthony J St Leger; Angus W Thomson; Thomas L Cherpes Journal: J Immunol Date: 2012-08-31 Impact factor: 5.422